scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1041298174 |
P356 | DOI | 10.1186/1297-9716-44-59 |
P932 | PMC publication ID | 3726328 |
P698 | PubMed publication ID | 23876077 |
P5875 | ResearchGate publication ID | 251233720 |
P50 | author | Ryoyo Ikebuchi | Q84977791 |
P2093 | author name string | Kazumasa Yokoyama | |
Chie Nakajima | |||
Yasuhiko Suzuki | |||
Kazuhiko Ohashi | |||
Satoru Konnai | |||
Shiro Murata | |||
Tomohiro Okagawa | |||
P2860 | cites work | Host soluble factors that regulate the synthesis of the major core protein of the bovine leukemia virus (BLV) in a naturally infected neoplastic B-cell line | Q39037937 |
Molecular characterization of immunoinhibitory factors PD-1/PD-L1 in chickens infected with Marek's disease virus | Q39345223 | ||
Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors | Q40738490 | ||
Molecular cloning and expression analysis of bovine programmed death-1. | Q43864810 | ||
Programmed death (PD)-1 molecule and its ligand PD-L1 distribution among memory CD4 and CD8 T cell subsets in human immunodeficiency virus-1-infected individuals | Q45382246 | ||
Induction of expression of bovine leukemia virus (BLV) in blood taken from BLV-infected cows without removal of plasma | Q45437673 | ||
Expression of bovine leukemia virus genome is blocked by a nonimmunoglobulin protein in plasma from infected cattle | Q45800791 | ||
Nomenclature and characterization of leukocyte differentiation antigens in ruminants | Q46847108 | ||
Cloning and identification of porcine programmed death 1. | Q53333415 | ||
Augmented expression of programmed death-1 in both neoplastic and non-neoplastic CD4+ T-cells in adult T-cell leukemia/lymphoma. | Q55239393 | ||
Aberrant regulation of synovial T cell activation by soluble costimulatory molecules in rheumatoid arthritis | Q56901733 | ||
The effects of purified mitogenic proteins (Pa-1 and Pa-2) from pokeweed on human T and B lymphocytes in vitro | Q66889525 | ||
Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human | Q21245197 | ||
Porcine PD-L1: cloning, characterization, and implications during xenotransplantation | Q24305180 | ||
Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection | Q24564396 | ||
Efficient selection for high-expression transfectants with a novel eukaryotic vector | Q27860810 | ||
PD-1 and its ligands in tolerance and immunity | Q28131650 | ||
Host immune responses in the course of bovine leukemia virus infection | Q28212667 | ||
Alternative splice variants of the human PD-1 gene | Q28273137 | ||
Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes | Q28282689 | ||
Functional and clinical aspects of the B-cell-activating factor (BAFF): a narrative review | Q28299847 | ||
Cutting edge: A monoclonal antibody specific for the programmed death-1 homolog prevents graft-versus-host disease in mouse models | Q28592282 | ||
Antigen load and viral sequence diversification determine the functional profile of HIV-1-specific CD8+ T cells | Q28754733 | ||
The immunobiology of cancer immunosurveillance and immunoediting | Q29616246 | ||
Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates | Q29620051 | ||
Feline programmed death and its ligand: characterization and changes with feline immunodeficiency virus infection | Q30157046 | ||
Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer | Q33842859 | ||
Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired | Q34080914 | ||
Programmed death-1 and its ligand are novel immunotolerant molecules expressed on leukemic B cells in chronic lymphocytic leukemia | Q34245048 | ||
Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity | Q34554995 | ||
Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction | Q34570127 | ||
Interaction between B7-H1 and PD-1 determines initiation and reversal of T-cell anergy | Q34575119 | ||
Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies | Q34592058 | ||
PD-1/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia/lymphoma patients. | Q34597843 | ||
Enhancing SIV-specific immunity in vivo by PD-1 blockade | Q34601856 | ||
PD-1 blockade in rhesus macaques: impact on chronic infection and prophylactic vaccination | Q34602682 | ||
On the role of the inhibitory receptor LAG-3 in acute and chronic LCMV infection | Q35010742 | ||
Peripheral blood B-cell death compensates for excessive proliferation in lymphoid tissues and maintains homeostasis in bovine leukemia virus-infected sheep | Q35101368 | ||
Increase of cells expressing PD-L1 in bovine leukemia virus infection and enhancement of anti-viral immune responses in vitro via PD-L1 blockade. | Q35364931 | ||
Progression to persistent lymphocytosis and tumor development in bovine leukemia virus (BLV)-infected cattle correlates with impaired proliferation of CD4+ T cells in response to gag- and env-encoded BLV proteins | Q35871823 | ||
Presence of suppressor HIV-specific CD8+ T cells is associated with increased PD-1 expression on effector CD8+ T cells | Q36666548 | ||
Transcriptional control of the bovine leukemia virus genome: role and characterization of a non-immunoglobulin plasma protein from bovine leukemia virus-infected cattle | Q36914668 | ||
Impact of epitope escape on PD-1 expression and CD8 T-cell exhaustion during chronic infection | Q37157206 | ||
Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways. | Q37256978 | ||
Gene activation therapy: from the BLV model to HAM/TSP patients | Q37502152 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | leukemia | Q29496 |
bovine leukemia virus | Q895365 | ||
bovine leukemia | Q11570209 | ||
cell function | Q95674809 | ||
P304 | page(s) | 59 | |
P577 | publication date | 2013-07-22 | |
P1433 | published in | Veterinary Research | Q15761008 |
P1476 | title | Blockade of bovine PD-1 increases T cell function and inhibits bovine leukemia virus expression in B cells in vitro | |
P478 | volume | 44 |
Q38617885 | (89)Zr-labeled nivolumab for imaging of T-cell infiltration in a humanized murine model of lung cancer. |
Q41488571 | A canine chimeric monoclonal antibody targeting PD-L1 and its clinical efficacy in canine oral malignant melanoma or undifferentiated sarcoma |
Q40150431 | Anti-Bovine Programmed Death-1 Rat-Bovine Chimeric Antibody for Immunotherapy of Bovine Leukemia Virus Infection in Cattle. |
Q90114979 | Approaches to overcome flow cytometry limitations in the analysis of cells from veterinary relevant species |
Q92576846 | Association between bovine leukemia virus proviral load and severity of clinical mastitis |
Q36411023 | Bovine Immunoinhibitory Receptors Contribute to Suppression of Mycobacterium avium subsp. paratuberculosis-Specific T-Cell Responses |
Q38638547 | Bovine leukemia virus reduces anti-viral cytokine activities and NK cytotoxicity by inducing TGF-β secretion from regulatory T cells |
Q39313794 | Comparative Analysis of Immune Checkpoint Molecules and Their Potential Role in the Transmissible Tasmanian Devil Facial Tumor Disease. |
Q39588896 | Cooperation of PD-1 and LAG-3 Contributes to T-Cell Exhaustion in Anaplasma marginale-Infected Cattle |
Q55347066 | Cooperation of PD-1 and LAG-3 in the exhaustion of CD4+ and CD8+ T cells during bovine leukemia virus infection. |
Q40778980 | Direct polymerase chain reaction from blood and tissue samples for rapid diagnosis of bovine leukemia virus infection. |
Q34979190 | Effects of bovine leukemia virus infection on milk neutrophil function and the milk lymphocyte profile |
Q35184928 | Expression of PD-L1 on canine tumor cells and enhancement of IFN-γ production from tumor-infiltrating cells by PD-L1 blockade |
Q42217541 | Identification and characterization of bovine programmed death-ligand 2. |
Q33605673 | In vitro and in vivo antivirus activity of an anti-programmed death-ligand 1 (PD-L1) rat-bovine chimeric antibody against bovine leukemia virus infection |
Q40198651 | Increase of cells expressing PD-1 and PD-L1 and enhancement of IFN-γ production via PD-1/PD-L1 blockade in bovine mycoplasmosis. |
Q51750565 | Influence of PD-L1 cross-linking on cell death in PD-L1-expressing cell lines and bovine lymphocytes. |
Q47195414 | Mycoplasma bovis induced inhibition of bovine PBMC proliferation is ameliorated after blocking the immune-inhibitory programmed death-1 (PD-1) receptor. |
Q58579943 | PD-1 blockade inhibits lymphocyte apoptosis and restores proliferation and anti-viral immune functions of lymphocyte after CP and NCP BVDV infection in vitro |
Q91636348 | PD-1-Mediated PI3K/Akt/mTOR, Caspase 9/Caspase 3 and ERK Pathways Are Involved in Regulating the Apoptosis and Proliferation of CD4+ and CD8+ T Cells During BVDV Infection in vitro |
Q52684416 | Prostaglandin E2 Induction Suppresses the Th1 Immune Responses in Cattle with Johne's Disease. |
Q92320686 | Prostaglandin E2-Induced Immune Exhaustion and Enhancement of Antiviral Effects by Anti-PD-L1 Antibody Combined with COX-2 Inhibitor in Bovine Leukemia Virus Infection |
Q41628406 | The Pekin duck programmed death-ligand 1: cDNA cloning, genomic structure, molecular characterization and mRNA expression analysis |
Q90603564 | The Possible Role of PD-1 Protein in Ganoderma lucidum-Mediated Immunomodulation and Cancer Treatment |
Q90182066 | Upregulation of PD-L1 Expression by Prostaglandin E2 and the Enhancement of IFN-γ by Anti-PD-L1 Antibody Combined With a COX-2 Inhibitor in Mycoplasma bovis Infection |
Search more.